美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Neuphoria Therapeutics Inc

4.59

+0.05001.10%

盤後：4.590.00000.00%16:10 EDT

成交量：2.77萬

成交額：12.62萬

市值：2,468.19萬

市盈率：-2.11

高：4.69

開：4.58

低：4.48

收：4.54

52周最高：21.40

52周最低：3.65

股本：537.73萬

流通股本：386.78萬

量比：0.34

換手率：0.72%

股息：- -

股息率：- -

每股收益(TTM):-2.1787

每股收益(LYR):-0.2278

淨資產收益率：-26.07%

總資產收益率：-4.25%

市淨率：0.83

市盈率(LYR):-20.15

資料載入中...

總覽公司新聞資訊公告

Lynx1資本管理公司於12月26日提出以現金或等值股票收購Neuphoria Therapeutics的知識產權資產——美國證券交易委員會文件披露

知名代理顧問公司ISS建議股東使用白色代理卡為Neuphoria的兩位董事提名人投票

Neuphoria Therapeutics Inc - 敦促股東在白色代理卡上投票支持Neuphoria的兩名提名人

Neuphoria Therapeutics Inc - 暫停Bnc210在創傷後應激障礙方面的研發支出，並在公司戰略評估中評估所有可能性

Lynx1 Capital Management向Neuphoria Therapeutics提出非約束性收購提議，報價為每股4.75美元現金

Lynx1 Capital Management Lp 於12月2日向Neuphoria Therapeutics董事會提交函件 - SEC備案

Lynx1 Capital Management Lp撤回收購Neuphoria Therapeutics的非約束性提議 - SEC備案

Neuphoria Therapeutics Inc - 可能不定期提供和銷售高達2000萬美元的普通股 - SEC文件

Neuphoria Therapeutics Inc - Lynx1 Master Fund在11月10日提供每股5.20美元現金收購Neuphoria

Neuphoria Therapeutics：確認收到Lynx1 Master Fund Lp的非正式投資意向及董事提名

Neuphoria Therapeutics Inc - 董事會宣佈每股發行一項優先股購買權的股息

Neuphoria Therapeutics通過有限期限股東權利計劃以保護過程的完整性

Neuphoria Therapeutics：可能不時提供和出售高達2190萬美元的普通股 - SEC 備案

BUZZ--美國股票走勢-Elevance、EPAM 系統、丹納赫

BUZZ--美國股票走勢-Elevance、EPAM 系統、丹納赫

Neuphoria股價因試驗失敗暫停焦慮藥物項目下跌65.8%至5.27美元

Neuphoria Therapeutics 股價在延長交易中下跌67.21%，報5.05美元；在第三階段試驗後停止焦慮藥物的開發

BUZZ-試驗失敗迫使焦慮症藥物項目停滯，Neuphoria 公司股價暴跌

Neuphoria Therapeutics更新Affirm-1三期試驗進展，評估Bnc210治療社交焦慮症急性發作

Neuphoria Therapeutics Inc在SAD治療藥物BNC-210的AFFIRM-1 III期試驗中達成LPLV里程碑，預計第四季度公布頂線數據

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/NEUP/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"NEUP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NEUP\",,,,,undefined,":{"symbol":"NEUP","market":"US","secType":"STK","nameCN":"Neuphoria Therapeutics Inc","latestPrice":4.59,"timestamp":1773691200000,"preClose":4.54,"halted":0,"volume":27660,"hourTrading":{"tag":"盘后","latestPrice":4.59,"preClose":4.59,"latestTime":"16:10 EDT","volume":3,"amount":13.77,"timestamp":1773691804851,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.011013215859030798,"floatShares":3867799,"shares":5377329,"eps":-2.1787,"marketStatus":"已收盤","change":0.05,"latestTime":"03-16 16:00:00 EDT","open":4.575,"high":4.688,"low":4.48,"amount":126151.8888,"amplitude":0.045815,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.1787,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1773734400000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":4.54,"preHourTrading":{"tag":"盘前","latestPrice":4.54,"preClose":4.54,"latestTime":"08:00 EDT","volume":2,"amount":9.08,"timestamp":1773662411834,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":4.59,"preClose":4.59,"latestTime":"16:10 EDT","volume":3,"amount":13.77,"timestamp":1773691804851,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.34323},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NEUP\",,,,,undefined,":{"symbol":"NEUP","floatShares":3867799,"roa":"-4.25%","roe":"-26.07%","lyrEps":-0.227756,"volumeRatio":0.34323,"shares":5377329,"dividePrice":0,"high":4.688,"amplitude":0.045815,"preClose":4.54,"low":4.48,"week52Low":3.645,"pbRate":"0.83","psRate":"1.65","week52High":21.4004,"institutionHeld":0.833,"latestPrice":4.59,"eps":-2.1787,"divideRate":0,"volume":27660,"delay":0,"ttmEps":-2.1787,"open":4.575,"prevYearClose":3.88,"prevWeekClose":4.54,"prevMonthClose":4.15,"prevQuarterClose":3.88,"fiveDayClose":4.54,"twentyDayClose":4.05,"sixtyDayClose":3.9},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NEUP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-17","symbol":"NEUP","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1771304400000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2025-11-14","symbol":"NEUP","fiscalQuarterEnding":"2025/09","expectedEps":-0.55,"name":null,"time":"盤後","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"post","actualEps":-4.41},{"market":"US","date":"2025-09-29","symbol":"NEUP","fiscalQuarterEnding":"2025/06","expectedEps":-0.56,"name":null,"time":"盤後","type":"earning","dateTimestamp":1759118400000,"reportTimeType":"post","actualEps":-5.79},{"market":"US","date":"2024-12-24","symbol":"NEUP","defaultRemindTime":1735050600000,"type":"split","dateTimestamp":1735016400000,"forFactor":12,"toFactor":1,"ratio":12}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NEUP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NEUP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.6667,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1761278400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NEUP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NEUP","date":"2026-03-13","current":-2.106761,"percent":0.142384,"low":-2152.911097,"twenty":-2.602552,"median":-1.093153,"eighty":2.305511,"high":4.870093,"avg":-34.401087,"sd":197.421387,"marketCap":25498933},"quantilePoints":[{"date":"2024-12-27","current":-1445.015744,"twenty":-2011.332026,"median":-1798.963421,"eighty":-1586.594815,"marketCap":15641406744},{"date":"2025-01-03","current":-951.437333,"twenty":-1445.015744,"median":-1245.311321,"eighty":-1113.798652,"marketCap":10298723991},{"date":"2025-01-10","current":-0.484092,"twenty":-1335.908938,"median":-1032.617992,"eighty":-0.531583,"marketCap":5240001},{"date":"2025-01-17","current":-0.452507,"twenty":-1207.318772,"median":-0.536694,"eighty":-0.48107,"marketCap":4898109},{"date":"2025-01-24","current":-0.524667,"twenty":-1141.075354,"median":-0.511137,"eighty":-0.48107,"marketCap":5679203},{"date":"2025-01-31","current":-0.81331,"twenty":-1016.381861,"median":-0.554735,"eighty":-0.482883,"marketCap":8803579},{"date":"2025-02-07","current":-0.757686,"twenty":-381.062919,"median":-0.702062,"eighty":-0.484985,"marketCap":8201486},{"date":"2025-02-14","current":-0.691539,"twenty":-0.803388,"median":-0.699056,"eighty":-0.486483,"marketCap":7485483},{"date":"2025-02-21","current":-1.080318,"twenty":-1.103422,"median":-0.706573,"eighty":-0.495533,"marketCap":8872986},{"date":"2025-02-28","current":-1.110267,"twenty":-1.105989,"median":-0.757686,"eighty":-0.509378,"marketCap":9118970},{"date":"2025-03-07","current":-1.180862,"twenty":-1.111551,"median":-0.770464,"eighty":-0.516549,"marketCap":9698789},{"date":"2025-03-14","current":-1.035394,"twenty":-1.111551,"median":-0.796773,"eighty":-0.529478,"marketCap":8504010},{"date":"2025-03-21","current":-1.108128,"twenty":-1.110267,"median":-1.022558,"eighty":-0.551126,"marketCap":9101399},{"date":"2025-03-28","current":-1.240761,"twenty":-1.1415,"median":-1.048229,"eighty":-0.607653,"marketCap":10190756},{"date":"2025-04-04","current":-1.210812,"twenty":-1.180862,"median":-1.055716,"eighty":-0.664779,"marketCap":9944772},{"date":"2025-04-11","current":-1.048229,"twenty":-1.179151,"median":-1.052508,"eighty":-0.679813,"marketCap":8609432},{"date":"2025-04-17","current":-1.093153,"twenty":-1.172305,"median":-1.056786,"eighty":-0.692441,"marketCap":8978407},{"date":"2025-04-25","current":-1.110267,"twenty":-1.154335,"median":-1.064274,"eighty":-0.697252,"marketCap":9118970},{"date":"2025-05-02","current":-1.069622,"twenty":-1.152624,"median":-1.071761,"eighty":-0.702663,"marketCap":8785135},{"date":"2025-05-09","current":-1.056786,"twenty":-1.146207,"median":-1.070692,"eighty":-0.70567,"marketCap":8679713},{"date":"2025-05-16","current":-1.014001,"twenty":-1.12567,"median":-1.069622,"eighty":-0.714089,"marketCap":8328307},{"date":"2025-05-23","current":1.878545,"twenty":-1.12567,"median":-1.066199,"eighty":-0.70567,"marketCap":10946278},{"date":"2025-05-30","current":2.090639,"twenty":-1.118824,"median":-1.058925,"eighty":-0.691539,"marketCap":12182153},{"date":"2025-06-06","current":2.306801,"twenty":-1.112407,"median":-1.056786,"eighty":-0.536694,"marketCap":13441728},{"date":"2025-06-13","current":2.303575,"twenty":-1.112407,"median":-1.053577,"eighty":-0.487084,"marketCap":13422928},{"date":"2025-06-20","current":2.135807,"twenty":-1.112407,"median":-1.052016,"eighty":-0.48107,"marketCap":12445348},{"date":"2025-06-27","current":2.193881,"twenty":-1.110695,"median":-1.048229,"eighty":-0.028511,"marketCap":12783741},{"date":"2025-07-03","current":2.300349,"twenty":-1.110267,"median":-1.04609,"eighty":1.971267,"marketCap":13404129},{"date":"2025-07-11","current":2.451984,"twenty":-1.110267,"median":-1.029511,"eighty":2.139033,"marketCap":14287711},{"date":"2025-07-18","current":2.416495,"twenty":-1.110267,"median":-1.009723,"eighty":2.183557,"marketCap":14080915},{"date":"2025-07-25","current":2.710088,"twenty":-1.108984,"median":-0.902959,"eighty":2.199559,"marketCap":15791680},{"date":"2025-08-01","current":2.616525,"twenty":-1.108128,"median":-0.783243,"eighty":2.258407,"marketCap":15246491},{"date":"2025-08-08","current":2.500379,"twenty":-1.107461,"median":-0.765954,"eighty":2.294542,"marketCap":14569705},{"date":"2025-08-15","current":2.613299,"twenty":-1.106066,"median":-0.738143,"eighty":2.306801,"marketCap":15227692},{"date":"2025-08-22","current":2.232596,"twenty":-1.104483,"median":-0.703565,"eighty":2.308091,"marketCap":13009337},{"date":"2025-08-29","current":3.939307,"twenty":-1.101283,"median":-0.691539,"eighty":2.322933,"marketCap":22954336},{"date":"2025-09-05","current":3.845744,"twenty":-1.099571,"median":-0.659969,"eighty":2.388052,"marketCap":22409147},{"date":"2025-09-12","current":4.513587,"twenty":-1.099503,"median":-0.53068,"eighty":2.412623,"marketCap":26300668},{"date":"2025-09-19","current":3.032718,"twenty":-1.096901,"median":-0.508206,"eighty":2.459921,"marketCap":17671642},{"date":"2025-09-26","current":4.016738,"twenty":-1.093153,"median":-0.484837,"eighty":2.484247,"marketCap":23405526},{"date":"2025-10-03","current":-93.377884,"twenty":-1.099571,"median":-0.487084,"eighty":2.484247,"marketCap":34515454},{"date":"2025-10-10","current":-121.187146,"twenty":-1.107683,"median":-0.517902,"eighty":2.484247,"marketCap":44794647},{"date":"2025-10-17","current":-96.758368,"twenty":-1.110267,"median":-0.572775,"eighty":2.482957,"marketCap":35764989},{"date":"2025-10-24","current":-25.831995,"twenty":-1.112407,"median":-0.681767,"eighty":2.474697,"marketCap":9548332},{"date":"2025-10-31","current":-28.064391,"twenty":-1.152196,"median":-0.702062,"eighty":2.459921,"marketCap":10373497},{"date":"2025-11-07","current":-27.298997,"twenty":-1.179151,"median":-0.72311,"eighty":2.450694,"marketCap":10090583},{"date":"2025-11-14","current":-30.296784,"twenty":-1.215946,"median":-0.765203,"eighty":2.444886,"marketCap":11198661},{"date":"2025-11-21","current":-2.390214,"twenty":-1.237338,"median":-0.778733,"eighty":2.430045,"marketCap":22638555},{"date":"2025-11-28","current":-2.566216,"twenty":-2.485596,"median":-0.805041,"eighty":2.414559,"marketCap":24305527},{"date":"2025-12-05","current":-2.424279,"twenty":-2.506035,"median":-0.994748,"eighty":2.406545,"marketCap":22961194},{"date":"2025-12-12","current":-2.259633,"twenty":-2.513983,"median":-1.018814,"eighty":2.405087,"marketCap":21401769},{"date":"2025-12-19","current":-2.208535,"twenty":-2.506035,"median":-1.043951,"eighty":2.402299,"marketCap":20917809},{"date":"2025-12-26","current":-2.151761,"twenty":-2.492409,"median":-1.048229,"eighty":2.397137,"marketCap":20380076},{"date":"2026-01-02","current":-2.202858,"twenty":-2.483325,"median":-1.048229,"eighty":2.378967,"marketCap":20864036},{"date":"2026-01-09","current":-2.31073,"twenty":-2.435634,"median":-1.052508,"eighty":2.369366,"marketCap":21885729},{"date":"2026-01-16","current":-2.327762,"twenty":-2.424279,"median":-1.055289,"eighty":2.331967,"marketCap":22047048},{"date":"2026-01-23","current":-2.367504,"twenty":-2.40384,"median":-1.056786,"eighty":2.322933,"marketCap":22423461},{"date":"2026-01-30","current":-2.282342,"twenty":-2.390214,"median":-1.06192,"eighty":2.319061,"marketCap":21616862},{"date":"2026-02-06","current":-2.268149,"twenty":-2.386808,"median":-1.069622,"eighty":2.31648,"marketCap":21482429},{"date":"2026-02-13","current":-2.31073,"twenty":-2.38113,"median":-1.071761,"eighty":2.312608,"marketCap":21885729},{"date":"2026-02-20","current":-4.064176,"twenty":-2.390214,"median":-1.079248,"eighty":2.308737,"marketCap":23019121},{"date":"2026-02-27","current":-4.149838,"twenty":-2.487867,"median":-1.081388,"eighty":2.306801,"marketCap":23504302},{"date":"2026-03-06","current":-4.321162,"twenty":-2.55259,"median":-1.084596,"eighty":2.306801,"marketCap":24474663},{"date":"2026-03-13","current":-4.502003,"twenty":-2.602552,"median":-1.093153,"eighty":2.305511,"marketCap":25498933}],"updateTime":1773707784594},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NEUP\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1112665789","title":"Lynx1資本管理公司於12月26日提出以現金或等值股票收購Neuphoria Therapeutics的知識產權資產——美國證券交易委員會文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1112665789","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112665789?lang=zh_tw&edition=fundamental","pubTime":"2025-12-30 05:41","pubTimestamp":1767044474,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会（SEC）最新披露的文件，Lynx1资本管理公司已于12月26日正式向Neuphoria Therapeutics Inc（NEUP）提出收购要约，计划以现金或等值股票方式获取该公司的知识产权资产。\n这一举措标志着资本市场对生物科技领域知识产权价值的持续关注。通过现金与股权结合的灵活收购方案，Lynx1资本管理展现出其对Neuphoria Therapeutics核心资产战略价值的认可，同时也为交易双方提供了多元化的合作路径。\n","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEUP","BK4139"],"gpt_icon":0},{"id":"1186846363","title":"知名代理顧問公司ISS建議股東使用白色代理卡為Neuphoria的兩位董事提名人投票","url":"https://stock-news.laohu8.com/highlight/detail?id=1186846363","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186846363?lang=zh_tw&edition=fundamental","pubTime":"2025-12-08 21:07","pubTimestamp":1765199235,"startTime":"0","endTime":"0","summary":"知名代理顾问公司ISS建议股东使用白色代理卡为Neuphoria的两位董事提名人投票","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEUP","BK4139"],"gpt_icon":0},{"id":"1178607496","title":"Neuphoria Therapeutics Inc - 敦促股東在白色代理卡上投票支持Neuphoria的兩名提名人","url":"https://stock-news.laohu8.com/highlight/detail?id=1178607496","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178607496?lang=zh_tw&edition=fundamental","pubTime":"2025-12-04 21:05","pubTimestamp":1764853516,"startTime":"0","endTime":"0","summary":"Neuphoria Therapeutics Inc - 敦促股东在白色代理卡上投票支持Neuphoria的两名提名人","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEUP","BK4139"],"gpt_icon":0},{"id":"1164604292","title":"Neuphoria Therapeutics Inc - 暫停Bnc210在創傷後應激障礙方面的研發支出，並在公司戰略評估中評估所有可能性","url":"https://stock-news.laohu8.com/highlight/detail?id=1164604292","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164604292?lang=zh_tw&edition=fundamental","pubTime":"2025-12-04 21:03","pubTimestamp":1764853402,"startTime":"0","endTime":"0","summary":"Neuphoria Therapeutics Inc - 暂停Bnc210在创伤后应激障碍方面的研发支出，并在公司战略评估中评估所有可能性","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEUP","BK4139"],"gpt_icon":0},{"id":"1127135911","title":"Lynx1 Capital Management向Neuphoria Therapeutics提出非約束性收購提議，報價為每股4.75美元現金","url":"https://stock-news.laohu8.com/highlight/detail?id=1127135911","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127135911?lang=zh_tw&edition=fundamental","pubTime":"2025-12-02 21:35","pubTimestamp":1764682510,"startTime":"0","endTime":"0","summary":"Lynx1 Capital Management向Neuphoria Therapeutics提出非约束性提议，计划以每股4.75美元的现金收购其所有流通股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEUP","BK4139"],"gpt_icon":0},{"id":"1188165374","title":"Lynx1 Capital Management Lp 於12月2日向Neuphoria Therapeutics董事會提交函件 - SEC備案","url":"https://stock-news.laohu8.com/highlight/detail?id=1188165374","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188165374?lang=zh_tw&edition=fundamental","pubTime":"2025-12-02 21:32","pubTimestamp":1764682337,"startTime":"0","endTime":"0","summary":"Lynx1 Capital Management Lp 于12月2日向Neuphoria Therapeutics董事会提交函件 - SEC备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NEUP"],"gpt_icon":0},{"id":"1125692194","title":"Lynx1 Capital Management Lp撤回收購Neuphoria Therapeutics的非約束性提議 - SEC備案","url":"https://stock-news.laohu8.com/highlight/detail?id=1125692194","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125692194?lang=zh_tw&edition=fundamental","pubTime":"2025-11-18 21:38","pubTimestamp":1763473129,"startTime":"0","endTime":"0","summary":"Lynx1 Capital Management Lp撤回了此前提出的收购Neuphoria Therapeutics的非约束性提议，并已在SEC备案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEUP","BK4139"],"gpt_icon":0},{"id":"1138335047","title":"Neuphoria Therapeutics Inc - 可能不定期提供和銷售高達2000萬美元的普通股 - SEC文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1138335047","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138335047?lang=zh_tw&edition=fundamental","pubTime":"2025-11-15 05:25","pubTimestamp":1763155509,"startTime":"0","endTime":"0","summary":"Neuphoria Therapeutics Inc - 可能不定期提供和销售高达2000万美元的普通股 - SEC文件","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEUP","BK4139"],"gpt_icon":0},{"id":"1143200172","title":"Neuphoria Therapeutics Inc - Lynx1 Master Fund在11月10日提供每股5.20美元現金收購Neuphoria","url":"https://stock-news.laohu8.com/highlight/detail?id=1143200172","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143200172?lang=zh_tw&edition=fundamental","pubTime":"2025-11-11 20:02","pubTimestamp":1762862533,"startTime":"0","endTime":"0","summary":"Neuphoria Therapeutics Inc - Lynx1 Master Fund在11月10日提供每股5.20美元现金收购Neuphoria","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEUP","BK4139"],"gpt_icon":0},{"id":"1162850350","title":"Neuphoria Therapeutics：確認收到Lynx1 Master Fund Lp的非正式投資意向及董事提名","url":"https://stock-news.laohu8.com/highlight/detail?id=1162850350","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162850350?lang=zh_tw&edition=fundamental","pubTime":"2025-11-11 20:01","pubTimestamp":1762862483,"startTime":"0","endTime":"0","summary":"Neuphoria Therapeutics：确认收到Lynx1 Master Fund Lp的非正式投资意向及董事提名","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEUP","BK4139"],"gpt_icon":0},{"id":"1154437346","title":"Neuphoria Therapeutics Inc - 董事會宣佈每股發行一項優先股購買權的股息","url":"https://stock-news.laohu8.com/highlight/detail?id=1154437346","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154437346?lang=zh_tw&edition=fundamental","pubTime":"2025-10-28 04:30","pubTimestamp":1761597014,"startTime":"0","endTime":"0","summary":"Neuphoria Therapeutics Inc - 董事会宣布每股发行一项优先股购买权的股息","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEUP","BK4139"],"gpt_icon":0},{"id":"1105322519","title":"Neuphoria Therapeutics通過有限期限股東權利計劃以保護過程的完整性","url":"https://stock-news.laohu8.com/highlight/detail?id=1105322519","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105322519?lang=zh_tw&edition=fundamental","pubTime":"2025-10-28 04:30","pubTimestamp":1761597014,"startTime":"0","endTime":"0","summary":"Neuphoria Therapeutics通过有限期限股东权利计划以保护过程的完整性","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEUP","BK4139"],"gpt_icon":0},{"id":"1151086403","title":"Neuphoria Therapeutics：可能不時提供和出售高達2190萬美元的普通股 - SEC 備案","url":"https://stock-news.laohu8.com/highlight/detail?id=1151086403","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151086403?lang=zh_tw&edition=fundamental","pubTime":"2025-10-27 21:45","pubTimestamp":1761572715,"startTime":"0","endTime":"0","summary":"Neuphoria Therapeutics：可能不时提供和出售高达2190万美元的普通股 - SEC 备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NEUP"],"gpt_icon":0},{"id":"2577822438","title":"BUZZ--美國股票走勢-Elevance、EPAM 系統、丹納赫","url":"https://stock-news.laohu8.com/highlight/detail?id=2577822438","media":"路透中文","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577822438?lang=zh_tw&edition=fundamental","pubTime":"2025-10-21 19:39","pubTimestamp":1761046762,"startTime":"0","endTime":"0","summary":"** Galapagos NV GLPG.O：BUZZ - CAR T宣布关闭业务后，股价创下近五年来最差表现。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251021:nL4T3W20SO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2168564065.EUR","BK4566","NEUP","PM","BK4129","FLR","LU2045819591.USD","DHR","DGX","IRDM","SGXZ99366536.SGD","ZION","UHS","NEM","IE00BSNM7G36.USD","ELV","LU1670711040.USD","BK4504","LU0912757837.SGD","LU1506573853.SGD","CVS","LU1267930490.SGD","LU1061106388.HKD","EPAM","LU1670627923.USD","IE00B7SZLL34.SGD","LU2125910500.SGD","LU2168564495.EUR","SG9999018857.SGD","MMM","IE0002270589.USD","GE","GM","LU0122379950.USD","LU0106261372.USD","HUM","LU0965509101.SGD","WRB","CNC","LU2168564222.USD","SGXZ51526630.SGD","HAL","LU2106854487.HKD","BK4206","LU0312595415.SGD","LU1323610961.USD","RTX"],"gpt_icon":1},{"id":"2577224808","title":"BUZZ--美國股票走勢-Elevance、EPAM 系統、丹納赫","url":"https://stock-news.laohu8.com/highlight/detail?id=2577224808","media":"路透中文","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577224808?lang=zh_tw&edition=fundamental","pubTime":"2025-10-21 19:39","pubTimestamp":1761046762,"startTime":"0","endTime":"0","summary":"** Galapagos NV GLPG.O：BUZZ - CAR T宣布关闭业务后，股价创下近五年来最差表现。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251021:nL4S3W20SO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1223083913.SGD","EPAM","LU0882574055.USD","IRDM","LU1023059493.AUD","LU0208291251.USD","IE00BFSS7M15.SGD","LU0943347566.SGD","LU1223082196.USD","LU0048573561.USD","BK4154","DGX","LU0096364046.USD","LU0456854461.SGD","ZION","LU0861579265.USD","WRB","LU0511384066.AUD","NEUP","GE","FLR","RTX","LU0426417589.USD","CVS","HUM","LU0029864427.USD","LU0820562030.AUD","DHR","IE00B19Z8X17.USD","LU0300736062.USD","NEM","PM","BK4501","ELV","GM","HAL","LU1883866441.USD","LU0300736492.USD","LU0354030511.USD","LU2552382132.HKD","LU0795875086.SGD","UHS","BK4564","MMM","LU0278409577.USD","LU0187121727.USD","CNC"],"gpt_icon":1},{"id":"1137881661","title":"Neuphoria股價因試驗失敗暫停焦慮藥物項目下跌65.8%至5.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1137881661","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137881661?lang=zh_tw&edition=fundamental","pubTime":"2025-10-21 16:29","pubTimestamp":1761035350,"startTime":"0","endTime":"0","summary":"Neuphoria股价因试验失败导致焦虑药物项目暂停，盘前下跌65.8%，报5.27美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEUP","BK4139"],"gpt_icon":0},{"id":"1179026626","title":"Neuphoria Therapeutics 股價在延長交易中下跌67.21%，報5.05美元；在第三階段試驗後停止焦慮藥物的開發","url":"https://stock-news.laohu8.com/highlight/detail?id=1179026626","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179026626?lang=zh_tw&edition=fundamental","pubTime":"2025-10-21 05:39","pubTimestamp":1760996350,"startTime":"0","endTime":"0","summary":"Neuphoria Therapeutics 股价在延长交易中下跌67.21%，报5.05美元；在第三阶段试验后停止焦虑药物的开发。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NEUP"],"gpt_icon":0},{"id":"2577896301","title":"BUZZ-試驗失敗迫使焦慮症藥物項目停滯，Neuphoria 公司股價暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2577896301","media":"路透中文","labels":["productRelease","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577896301?lang=zh_tw&edition=fundamental","pubTime":"2025-10-21 05:11","pubTimestamp":1760994685,"startTime":"0","endTime":"0","summary":"BUZZ-试验失败迫使焦虑症药物项目停滞，Neuphoria 公司股价暴跌10月20日 - ** 药物开发商Neuphoria Therapeutics NEUP.O股价在延时交易中下跌72%，至4.30美元** 该公司称，其治疗社交焦虑症的实验性药物在一项后期试验中未能 ，因此NEUP停止了该项目的开发。** 该公司正在社交焦虑症患者中测试 BNC210 药物，但该药物并未达到其主要目标，即减少公众演讲挑战中的痛苦。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251020:nL4S3W10XF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"BUZZ-试验失败迫使焦虑症药物项目停滞，Neuphoria 公司股价暴跌","news_tag":"productRelease,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NEUP"],"gpt_icon":0},{"id":"1102819182","title":"Neuphoria Therapeutics更新Affirm-1三期試驗進展，評估Bnc210治療社交焦慮症急性發作","url":"https://stock-news.laohu8.com/highlight/detail?id=1102819182","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102819182?lang=zh_tw&edition=fundamental","pubTime":"2025-10-21 04:16","pubTimestamp":1760991368,"startTime":"0","endTime":"0","summary":"Neuphoria Therapeutics更新Affirm-1三期试验进展，评估Bnc210治疗社交焦虑症急性发作","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEUP","BK4139"],"gpt_icon":0},{"id":"1192631265","title":"Neuphoria Therapeutics Inc在SAD治療藥物BNC-210的AFFIRM-1 III期試驗中達成LPLV里程碑，預計第四季度公布頂線數據","url":"https://stock-news.laohu8.com/highlight/detail?id=1192631265","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192631265?lang=zh_tw&edition=fundamental","pubTime":"2025-09-30 04:57","pubTimestamp":1759179434,"startTime":"0","endTime":"0","summary":"Neuphoria Therapeutics Inc在其BNC-210治疗季节性情感障碍(SAD)的AFFIRM-1 III期试验中成功达成LPLV里程碑，预计将在第四季度公布顶线研究结果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NEUP"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":23,"code":"91000000","status":"200"}]}}